A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults

NCT07465965 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight
Obesity

Interventions

DRUG: Semaglutide Nasal Spray
DRUG: Placebo
DRUG: Semaglutide Injection

Sponsor

Shanghai World Leader Pharmaceutical Co., Ltd.